Samsung Galaxy Watch 8 (HSAT) vs Sunrise Home Sleep Test - Clinical Comparison

Samsung Galaxy Watch 8 (HSAT)

The Samsung Galaxy Watch 8 and Galaxy Watch 8 Classic represent a significant advancement in wearable medical technology for home use[cite: 1176]. The device is centered around the Samsung Health Monitor app, which provides FDA-cleared electrocardiograph (ECG) and sleep apnea pre-screening features[cite: 411, 1235]. For respiratory health, the watch identifies signs of moderate-to-severe obstructive sleep apnea (OSA) by monitoring relative decreases in blood oxygen levels during sleep[cite: 1241, 1242]. This feature requires at least two nights of successful measurements with a minimum of four hours of sleep each night to provide notification[cite: 1240, 1242]. The ECG function is capable of recording single-channel Lead I rhythms to identify episodes suggestive of Atrial Fibrillation (AFib)[cite: 433, 441, 450]. Clinical validation of the ECG algorithm demonstrated a sensitivity of 96.0% for AFib and 98.7% specificity for sinus rhythm[cite: 476, 1010]. Beyond these core clinical functions, the Watch 8 introduces innovative metabolic and vascular load tracking, as well as an advanced glycation end products (AGEs) index to monitor long-term lifestyle impact[cite: 1201, 1208, 1209]. While highly accurate as a screening tool, it is not intended to replace traditional hospital-grade diagnostic methods[cite: 995, 1187, 1235].

Sunrise Home Sleep Test

The Sunrise home sleep apnea test (HSAT) introduces a paradigm shift in diagnostics by focusing on mandibular jaw movements (MJM) as a proxy for respiratory effort. Traditional home tests often struggle with patient compliance due to uncomfortable wires, but Sunrise uses a single 3-gram sensor placed on the chin, which connects via Bluetooth to a smartphone app. This sensor tracks the trigeminal nerve drive, providing a high-fidelity look at how the brain regulates breathing during sleep. Landmark results from the SUNSAS trial demonstrated that the Sunrise diagnostic pathway can reduce the wait time for treatment initiation by more than 50% compared to traditional in-lab polysomnography (PSG). Beyond mere apnea detection, the device provides clinically validated sleep staging, respiratory effort-related arousals (RERAs), and differentiates between central and obstructive events. Its multi-night capability further enhances diagnostic confidence by capturing night-to-night variability.